comparemela.com

Latest Breaking News On - Thomas william burns - Page 1 : comparemela.com

Glaukos : Q1 2024 Earnings Transcript - MarketScreener

Glaukos (NYSE:GKOS) Shares Up 3.7%

Glaukos Co. (NYSE:GKOS – Get Free Report)’s share price shot up 3.7% during mid-day trading on Wednesday . The company traded as high as $93.64 and last traded at $92.80. 45,464 shares were traded during mid-day trading, a decline of 93% from the average session volume of 694,040 shares. The stock had previously closed at […]

Thomas-william-burns
Piper-sandler
Alexr-thurman
Wells-fargo-company
Glaukos-corporation
Pricet-rowe-associates-inc
Citigroup
Systematic-portfolios
Nomura-holdings-inc
Goldman-sachs-group-inc
Glaukos-co
Glaukos-company-profile

Analysts Set Glaukos Co. (NYSE:GKOS) Target Price at $92.80

Shares of Glaukos Co. (NYSE:GKOS – Get Free Report) have been given an average rating of “Moderate Buy” by the nine ratings firms that are presently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 1-year target […]

Canada
Alexr-thurman
Piper-sandler
Thomas-william-burns
Quadrant-capital-group
Tower-research-capital
National-bank
Needham-company
Glaukos-corporation
Wells-fargo-company
Glaukos-co
Morgan-stanley

Glaukos Co. (NYSE:GKOS) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Glaukos Co. (NYSE:GKOS – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the nine brokerages that are presently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average twelve-month price objective […]

Alger
Algeria
Piper-sandler
Thomas-william-burns
Markj-foley
Glaukos-corporation
Fred-alger-management
Glaukos-co
Wells-fargo-company
Brown-capital-management
Citigroup
Vanguard-group-inc

Glaukos (NYSE:GKOS) Earns "Buy" Rating from Truist Financial

Truist Financial reaffirmed their buy rating on shares of Glaukos (NYSE:GKOS – Free Report) in a research report released on Friday morning, Benzinga reports. Truist Financial currently has a $110.00 price objective on the medical instruments supplier’s stock. GKOS has been the topic of several other reports. Wells Fargo & Company lifted their price target […]

Gilberth-kliman
Thomas-william-burns
Piper-sandler
Morgan-stanley
Wells-fargo-company
Pricet-rowe-associates-inc
Goldman-sachs-group-inc
Barclays-plc
Glaukos-corporation
Systematic-portfolios
Fisher-asset-management
Truist-financial

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.